Biolase Reports Full-Year 2023 Results; Expects Continued Revenue Growth In 2024 [Yahoo! Finance]
Biolase, Inc. (BIOL)
Last biolase, inc. earnings: 3/26 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
biolase.com/investors
Company Research
Source: Yahoo! Finance
announced its preliminary financial results for the fourth quarter and full year ended December 31, 2023, today reported its financial results for the quarter and full year. 2023 Full-Year Highlights Achieved revenue growth despite industry headwinds and a challenging interest rate environment throughout 2023. Key performance metrics demonstrate continued growth and momentum, including: Record consumable sales, including the introduction of recurring revenue subscriptions. Increased adoption of its industry-leading laser systems. Increased sales conversion rate of 45% due to the continued success of its Waterlase Trial Program. Achieved cost savings goals and improved quality from in-house manufacturing of critical components. "We were operating in a challenging spending environment given higher interest rates. However, our initiatives enabled us to grow full-year 2023 revenue modestly," commented John Beaver, President and Chief Executive Officer of BIOLASE. "Our cont
Show less
Read more
Impact Snapshot
Event Time:
BIOL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
BIOL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
BIOL alerts
High impacting Biolase, Inc. news events
Weekly update
A roundup of the hottest topics
BIOL
News
- BIOLASE, Inc. (NASDAQ: BIOL) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- BIOLASE, Inc. (NASDAQ: BIOL) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- Global Dental Lasers Market to Witness Upsurge in Growth at a CAGR of ~5% by 2030 | DelveInsight [Yahoo! Finance]Yahoo! Finance
- BIOLASE, Inc. (NASDAQ: BIOL) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
- BIOLASE, Inc. (NASDAQ: BIOL) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.MarketBeat
BIOL
Sec Filings
- 4/23/24 - Form 424B4
- 4/23/24 - Form EFFECT
- 4/19/24 - Form POS
- BIOL's page on the SEC website